|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online February 15, 2008
Journal of Experimental Biology 211, 824-833 (2008)
Published by The Company of Biologists 2008
doi: 10.1242/jeb.011866
Pharmacology of ionotropic and metabotropic glutamate receptors on neurons involved in feeding behavior in the pond snail, Helisoma trivolvis
1 Program in Neuroscience, Bates College, Lewiston, ME 04240, USA
2 Department of Biology, Neuroscience and Cognitive Sciences Program, University
of Maryland, College Park, MD 20742, USA
3 Department of Biological Sciences and Laboratory of Integrative Neuroscience,
University of Illinois at Chicago, Chicago, IL 60607, USA
* Author for correspondence (e-mail: nkleckne{at}bates.edu)
Accepted 2 January 2008
| Summary |
|---|
|
|
|---|
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/KA-like
receptors. However, electrotonic coupling between B19 and B27 neurons, and a
lack of effect of KA on isolated B19 neurons suggest the excitatory effects of
KA on this neuron are indirect. These findings suggest the presence of
multiple glutamate receptor subtypes in molluscan neurons that do not always
resemble vertebrate receptors pharmacologically.
Key words: Helisoma, glutamate receptors, ionotropic, metabotropic
| INTRODUCTION |
|---|
|
|
|---|
Glutamate has been shown to be a major neurotransmitter controlling the
feeding behavior of Helisoma. It both excites S2 motor neurons and
inhibits S1 and S3 motor neurons of the buccal ganglia, effects that mimic
stimulation of the S2 interneuron B2. In addition, B2 neurons are labeled by
anti-glutamate antibodies (Quinlan et al.,
1995
). These studies suggest that B2 neurons are glutamatergic,
and the responses of motor neurons to B2 stimulation are likely to be mediated
by glutamate receptors. The excitatory response of an S2 motor neuron (B27) in
the buccal ganglia is mimicked by application of the ionotropic glutamate
receptor (iGluR) agonist kainate (KA), and is inhibited by
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an antagonist of the mammalian
excitatory amino acid receptors (Quinlan
and Murphy, 1991
). A receptor (Lym-eGluR2) with similar
pharmacology has been cloned from the nervous system of Lymnaea
stagnalis and shows 44–48% amino acid sequence homology to
vertebrate GluR5, 6 and 7 KA receptor subunits
(Stuhmer et al., 1996
).
Lym-eGluR2, when expressed in oocytes, is activated by glutamate and KA, and
these currents in turn are blocked by CNQX. The pharmacology of the receptors
and their localization to neurons of the buccal ganglia suggest a role for
these receptors in feeding. It is hypothesized, therefore, that the excitatory
glutamate receptors present in Helisoma B27 buccal neurons
(Quinlan and Murphy, 1991
) may
be similar to these.
The receptors responsible for hyperpolarization by glutamate in S1 and S3
motor neurons in Helisoma, and in invertebrate neurons in general,
are much less well understood. These receptors are not sensitive to any of the
antagonists associated with mammalian ionotropic glutamate receptors and the
inhibition is mimicked by application of quisqualic acid
(Quinlan and Murphy, 1991
), an
analog of glutamate that also activates inhibitory responses in the pulmonate
molluscs Helix, Lymnaea, Aplysia and Planorbarius
(Bolshakov et al., 1991
;
Walker, 1976
;
Katz and Levitan, 1993
). Some
of the inhibitory actions of glutamate and quisqualic acid are thought to be
mediated by the opening of an integral chloride channel
(Cleland, 1996
) and are often
activated by ibotenic acid. However, a glutamate-induced reduction in AP
frequency was not blocked by the Cl– channel antagonist
niflumic acid in Helisoma B5 and B19 neurons
(Kleckner et al., 2003
). Other
inhibitory glutamate actions are thought to be due to an increase in
K+ conductance, most likely through activation of metabotropic
glutamate receptors (mGluRs). The mGluR agonist
(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) was
effective in activating the K+ conductance in Aplysia
buccal neurons (Katz and Levitan,
1993
), but was ineffective in altering membrane potential or AP
frequency in Helisoma B19 neurons
(Quinlan and Murphy, 1991
). In
Planorbarius, at least two separate receptors are thought to mediate
an increase in K+ conductance, each with a different agonist
pharmacology (Bolshakov et al.,
1991
). Preliminary studies have shown that hyperpolarizations
caused by glutamate in Helisoma B5, a neuron sporadically active
during S1, and B19, an S3 motor neuron, are blocked by both pertussis toxin
and Ca2+ and Ba2+, suggesting a role for Gi/o
G proteins and K+ channels in the response
(Rafferty and Kleckner, 2005
).
Therefore, it is hypothesized that the receptors mediating inhibition in these
neurons are similar to vertebrate mGluRs that mediate inhibition, such as
group II or III receptors (Conn and Pin,
1997
; Sharon et al.,
1997
; Knoflach and Kemp,
1998
).
The purpose of the experiments described here was to characterize the excitatory and inhibitory glutamate receptors that respond to glutamate in three buccal neurons, B5, B27 and B19, associated with the S1, S2 and S3 phases of the feeding motor pattern, and influenced by release of glutamate from B2 interneurons. Unexpectedly, we found that all three neurons are inhibited by bath application of glutamate and excited by bath application of KA, suggesting that either each neuron has at least one excitatory and one inhibitory type of glutamate receptor, or that synaptic and electrotonic coupling of certain neuron pairs is responsible for these effects. Receptors mediating inhibition have a unique pharmacology compared with vertebrate receptors.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Ganglia preparation
De-shelled snails were place in 20% Listerine for 10 min before being
pinned in a dissection dish filled with Helisoma saline (HS; 51.3
mmol l–1 NaCl, 1.7 mmol l–1 KCl, 1.5 mmol
l–1 MgCl2, 4.1 mmol l–1
CaCl2, 5 mmol l–1 Hepes, pH 7.8). The central
nervous system of the snail, which includes the central nerve ring and the
buccal ganglia, was removed through a longitudinal incision on the dorsal
surface of the snail. Each ganglia preparation was pinned loosely to a small
Sylgard-covered dish, bathed in 0.5% protease (Sigma, St Louis, MO, USA) in
saline for 1.5–2 min, and rinsed three times with saline. Ganglia
preparations were then tightly re-pinned caudal side up with 0.1 mm minuten
pins. A map of some of the neurons in the buccal ganglia (see
Quinlan et al., 1995
) allowed
for identification of neurons B5, B19 and B27 based on size and location
relative to each other and to the processes exiting the buccal ganglia
(Fig. 1A).
|
Electrophysiology
Membrane potential changes in B5, B19 and B27 were measured with standard
intracellular recording techniques. Intracellular glass electrodes filled with
3 mol l–1 potassium acetate with resistances between 10 and
40 M
were used to measure the membrane potential of neurons during
perfusion with pharmacological agents. Preparations were perfused with varying
concentrations of the following glutamate agonists and antagonists, all
obtained from Sigma or Tocris (Ellisville, MO, USA): glutamate,
(S)-
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA)/KA receptor agonist KA, AMPA/KA receptor antagonist CNQX, non-specific
mGluR agonists quisqualate and ACPD, group I mGluR agonist
3,5-dihydrophenylglycine (DHPG), group II mGluR agonist
(2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine
(DCG-IV), and group III mGluR agonist L-2-amino-4-phosphonobutyric
acid (L-AP4). Between agonist perfusions, the ganglia were perfused
with Helisoma saline for several minutes to ensure that the previous
drug did not remain on the preparation. Membrane potentials were measure with
a Neuroprobe amplifier (A-M Systems, Sequim, WA, USA) and permanent recordings
were stored and analyzed with a Datapac 2K2 data acquisition and analysis
system (Run Technologies, Mission Viejo, CA, USA).
Lucifer Yellow injections
Some neurons were injected with Lucifer Yellow (LY; Sigma) to verify
accurate electrode placement. In these cases, electrode tips were filled with
LY (5% in 0.1 mol l–1 LiCl) and shanks were backfilled with
0.1 mol l–1 LiCl. Following pharmacological experiments, as
described above, neurons were injected with LY by application of –5.0 nA
of current to the electrode for 3–5 min. Following approximately 1 h of
incubation in Helisoma saline to allow for diffusion of the dye,
ganglia were preserved by incubation overnight (12–16 h) in 4%
paraformaldehyde in phosphate-buffered saline (PBS; 0.1 mol
l–1, pH 7.3) at 4°C. Ganglia were rinsed in PBS and
dehydrated in an ethanol series (50%, 70%, 80%, 90%, 100%, 100%) at room
temperature for 10 min each, followed by incubation in methyl salicylate for
30 min at room temperature. Ganglia were mounted between two coverslips in
methyl salicylate, and visualized with a Nikon 80i (with differential
interference contrast, DIC) or TE2000U (with Hoffman modulation contrast, HMC)
microscope (Melville, NY, USA) equipped with epifluorescence and a QImaging
Retiga fast monochrome camera (Surry, BC, Canada) and MetaView imaging system
(Molecular Devices, Downington, PA, USA), or a Spot Insight 2 megapixel camera
and Spot Advanced imaging software (Diagnostic Instruments, Sterling Heights,
MI, USA). Separate fluorescence and either HMC or DIC images were combined
using layers with a linear dodge, and processed using levels and curves to
control contrast and brightness as well as unsharp mask to increase sharpness
in Adobe Photoshop CS2. In some cases, the fluorescence image was created in
Helicon Focus (Helicon Soft, Kharkov, Ukraine) from a stack of separate images
to maximize the depth of field.
Statistical analysis
Datapac2K2 was used to measure changes in AP frequency in response to drug
treatments. Firing rates (Hz) were determined from 30–40 s intervals
during the application of each drug or saline and are presented as mean AP
frequency ±s.e.m. Student's two-tailed paired t-tests were
used to compare control and (one) drug-induced firing rates, and repeated
measures one-way ANOVA was performed, as was appropriate, to compare the
effects of the application of drug combinations or multiple concentrations of
drugs on neuronal firing rate. Neuman–Keuls multiple comparison tests
were performed when ANOVA indicated the effect of drug application on firing
rate was significant (P<0.05).
|
| RESULTS |
|---|
|
|
|---|
|
Neuron B5
In B5 neurons, glutamate produced a significant, dose-dependent inhibition
of AP firing (Fig. 1C,D;
one-way ANOVA, F3,6=3.403, P<0.05,
N=7). In pairwise comparisons, 300 µmol l–1
glutamate significantly reduced the firing rate from 0.76±0.34 Hz to
0.0±0.0 Hz (Neuman–Keuls post-hoc comparison,
P<0.05, N=7), while the reductions in firing rate in
response to 30 and 100 µmol l–1 glutamate to
0.39±0.19 and 0.09±0.06 Hz (N=7) were not significant.
These results confirm that inhibitory glutamate receptors are present on B5
neurons.
B5 neurons had a variable response to KA, with a reduction in AP frequency at 10 µmol l–1 (Student's two-tailed t-test, P<0.05, N=9; Fig. 1E,F), and a trend toward increased firing rate at 30 µmol l–1 (N=9). One-way ANOVA indicated a significant effect on firing rate of 10 µmol l–1 KA, 50 µmol l–1 CNQX and KA plus CNQX (F3,8=3.801, P<0.05, N=9; Fig. 1F).
Neuron B19
Neuron B19 is a motor neuron active in phase III of feeding, and its
processes extend across the buccal commissure and out through both ventral
buccal nerves (VBNs) and the ipsilateral lateral buccal nerve (LBN;
Fig. 2A,B)
(Murphy, 2001
). A significant,
dose-dependent inhibition of AP frequency was observed in B19 neurons
following bath application of glutamate (one-way ANOVA,
F3,8=10.03, P=0.0002, N=9), confirming
the presence of inhibitory glutamate receptors on these neurons
(Fig. 2C,D). Glutamate at 100
and 300 µmol l–1 caused significant reductions in firing
rate from the control rate of 2.88±0.68 Hz to 0.43±0.32 Hz
(P<0.05) and 0.31±0.29 Hz (P<0.05,
Neuman–Keuls post-hoc test), respectively. Application of 30
µmol l–1 glutamate reduced firing rate to 2.00±0.77
Hz (N=9).
KA has been shown to stimulate B19 neurons, suggesting the presence of a
second type of glutamate receptor in these cells
(Quinlan and Murphy, 1991
). To
further characterize this effect, 10 and 30 µmol l–1 KA
were applied while recording from B19 neurons. KA (10 µmol
l–1) did not significantly increase the firing rate (control,
1.54±0.50 Hz; 10 µmol l–1 KA, 2.24±0.47 Hz;
paired t-test, P=0.068, N=9), while 30 µmol
l–1 KA significantly increased the firing rate from
1.55±0.44 Hz to 2.59±0.46 Hz (paired t-test,
P<0.03, N=13). CNQX (50 µmol l–1) had
no effect on firing rate in the presence or absence of 10 µmol
l–1 KA (Fig.
2F; one-way ANOVA, F3,8=1.666,
P=0.20, N=9). Lower concentrations of CNQX, or 50 µmol
l–1 CNQX applied with higher concentrations of KA also had no
effect on the KA-induced firing rate in any cell type tested (data not
shown).
|
Quinlan and Murphy (Quinlan and Murphy,
1991
) found that bath application of 1 mmol l–1
glutamate inhibited B19 and excited B27, contrary to this study's findings
that 100 and 300 µmol l–1 glutamate inhibited both
neurons. This contradiction indicated a possible differential effect of
glutamate depending on its concentration, so the effects of a higher glutamate
concentration on B27 neurons were examined. The results were highly variable.
Glutamate at 3 mmol l–1 increased the firing rate of three
neurons, depolarized two others that were not firing, and hyperpolarized and
reduced the firing rate of three others. No significant effect on firing rate
was observed when the six firing neurons were combined (data not shown). This
variability in responsiveness indicates that additional unidentified factors
may modulate the effect of glutamate on B27, and that there may be individual
variability in the relative sizes of inhibitory and excitatory glutamate
receptor populations within a given type of neuron. However, excitation in B27
was never observed in response to lower concentrations of glutamate (30, 100
and 300 µmol l–1), indicating that the direction of effect
of glutamate on this neuron may vary with concentration.
As expected, KA increased the firing rate of B27 neurons (Fig. 3E). KA at 10 µmol l–1 did not have a significant effect on firing rate (paired t-test; control, 1.48±0.66 Hz; 10 µmol l–1 KA, 4.31±1.22 Hz; P=0.058, N=9), whereas 30 µmol l–1 KA produced a significant increase from 3.47±0.69 Hz to 6.86±0.81 Hz (paired t-test, P<0.0002, N=10). There was a significant effect of 10 µmol l–1 KA, 50 µmol l–1 CNQX and 10 µmol l–1 KA/50 µmol l–1 CNQX on firing rate in B27 neurons (one-way ANOVA, F3,8=4.60, P=0.0112, N=9). In pairwise comparisons, 10 µmol l–1 KA significantly increased AP frequency compared with both control and CNQX (Neuman–Keuls post-hoc comparison, P<0.05; data the same as Fig. 3E). However, CNQX in the presence of KA did not significantly reduce AP frequency compared with KA-induced excitation (4.31±1.22 Hz to 2.21±0.98 Hz, P>0.05, N=9; Fig. 3G). Pairwise comparison also indicated no significant difference between control and KA/CNQX firing rates, suggesting that KA was ineffective at increasing AP frequency in the presence of CNQX.
Electrotonic coupling and direct effects of agonists
Because of the unexpected inhibitory effects of glutamate on B27 neurons
and the excitatory effects of KA on B19 neurons, the electrotonic coupling
between neurons B27 and B19 was examined. During simultaneous intracellular
recordings of B27 and B19 neurons, hyperpolarizing current injected into
neuron B19 produced a hyperpolarization in the membrane potential of B27
(Fig. 4A). This demonstrates
electrotonic coupling between these neurons and suggests that the apparent
hyperpolarization and reduction of AP frequency of B27 neurons by glutamate,
and the depolarization and increase in AP frequency of B19 by KA might be
indirect.
To further test this hypothesis, the preliminary effects of the application
of glutamate and KA were tested on individually isolated B19 neurons in cell
culture. Only neurons that were removed from the buccal ganglia with partial
neurites intact were used for experimentation. This criterion increases the
probability that peripheral receptors would be retained in cultured neurons.
Individually isolated identified Helisoma neurons retain electrogenic
capabilities, and can release transmitter and respond to chemical receptor
stimulation in culture (Haydon and
Man-Son-Hing, 1988
; Syed et
al., 1993
). All data were collected from isolated neurons that
could produce APs in response to injection of depolarizing current.
KA and glutamate had differential effects on isolated B19 neurons (Fig. 4B). Bath application of 10 µmol l–1 KA had no apparent effect on the membrane potential of an individually isolated B19 neuron. This same isolated neuron produced a robust hyperpolarization in response to application of 1 mmol l–1 glutamate (N=3). The hyperpolarizing effect of glutamate application on B19 neurons was completely reversible. These data suggest that the effect of KA on B19 neurons in whole-ganglion preparations is the result of electrotonic coupling with B27 neurons.
|
Quisqualate and ACPD, non-selective agonists of most mGluRs
(Conn and Pin, 1997
), were
applied to investigate the presence of glutamate receptors resembling
vertebrate mGluRs on B5, B19 and B27 neurons. Additionally, the more selective
vertebrate mGluR agonists DHPG, DCG-IV and L-AP4 were applied to
more specifically classify inhibitory glutamate receptors as resembling
vertebrate group I, II and III mGluRs, respectively, in B5, B19 and B27
neurons.
Neuron B5
Quisqualate and ACPD reduced AP frequency significantly in B5 neurons.
Quisqualate (10 µmol l–1) reduced AP frequency in B5
neurons from 0.56±0.13 Hz to 0.008±0.007 Hz (paired
t-test, P=0.0007, N=15;
Fig. 5B). Likewise, 100 µmol
l–1 ACPD significantly reduced AP frequency, from
1.03±0.31 Hz to 0.33±0.25 Hz (paired t-test,
P=0.0061, N=13). None of the selective mGluR agonists, DHPG
(100 µmol l–1), DCG-IV (30 µmol l–1)
or L-AP4 (100 µmol l–1) had significant
inhibitory effects on AP firing in B5. These results suggest that the agonist
binding sites on mGluRs in Helisoma buccal neurons, while capable of
binding to glutamate and non-selective agonists, do not closely resemble the
binding conformations on vertebrate group I, II and III mGluRs.
Neuron B19
In response to 10 µmol l–1 quisqualate, a reduction in
AP frequency occurred in B19 neurons, verifying that inhibitory mGluRs are
present on these buccal neurons. Quisqualate caused AP frequency to decrease
from 1.179±0.16 Hz to 0.11±0.10 Hz (paired t-test,
P<0.0001, N=20; Fig.
5C). Neither ACPD nor any of the selective mGluR agonists, DHPG,
DCG-IV and L-AP4, had significant effects on the AP firing rate in
B19 neurons (Fig. 5C). These
results indicate that inhibitory receptors responsive to quisqualate are
present on B19 neurons, but they are insensitive to ACPD, and do not resemble
vertebrate group I, II or III mGluRs with respect to agonist binding.
Neuron B27
Quisqualate (10 µmol l–1) produced a significant
inhibitory effect on AP frequency in B27 neurons
(Fig. 5D). AP frequency
decreased from 3.21±0.81 Hz to 1.3±0.74 Hz (paired
t-test, P=0.046, N=9). ACPD (100 µmol
l–1), DHPG (100 µmol l–1), DCG-IV (30
µmol l–1) and L-AP4 (100 µmol
l–1) did not affect AP frequency in B27 neurons
(Fig. 5D). These results
suggest the presence of an mGluR on B27 neurons, but it is not sensitive to
ACPD or the selective agonists for vertebrate mGluR subtypes used in this
study.
| DISCUSSION |
|---|
|
|
|---|
A surprising finding that emerged from the data was that glutamate, at
concentrations between 100 and 300 µmol l–1, reduced AP
frequency in B27 neurons. These neurons have previously been found to be
activated by stimulation of the phase II glutamatergic interneuron B2, and by
perfusion of 1 mmol l–1 glutamate
(Quinlan et al., 1995
), so
glutamate was expected to stimulate the cells. Results with a higher
concentration, 3 mmol l–1, of glutamate were highly variable.
These data suggest that different B27 neurons might have different relative
numbers of excitatory and inhibitory glutamate receptors, leading to an
inconsistent response to high concentrations of perfused glutamate.
Nevertheless, if we assume the presence of a significant number of inhibitory
glutamate receptors on B27 neurons, it is interesting to speculate on why
stimulation of interneuron B2 consistently causes depolarization and increased
firing rate (Quinlan and Murphy,
1991
). The most likely interpretation is that ionotropic glutamate
receptors, which cause depolarization, are located in synapses, and
metabotropic receptors, which are hypothesized to cause hyperpolarization, are
located extrasynaptically. Thus, ionotropic glutamate receptors are exposed to
high concentrations of glutamate in the synapse, and metabotropic receptors to
lower concentrations. This organization has been observed in many vertebrate
systems (Conn and Pin, 1997
).
High frequency activation of presynaptic neurons is thought to be required to
cause the spill-over of glutamate and subsequent activation of extra-synaptic
glutamate receptors. Perhaps this organization of receptors on buccal motor
neurons in the feeding CPG of Helisoma would provide modulation
during times of high activity.
An alternative explanation for the inhibitory effects of glutamate on B27 neurons is provided by evidence for electrotonic coupling between B19 and B27 neurons. Glutamate actions on mGluRs located on B19 neurons could hyperpolarize B27 and counteract the effects of glutamate on excitatory receptors present on B27. The similar effects of metabotropic agonists on B19 and B27 neurons (see below) supports this explanation. A full explanation of the inhibitory effects of glutamate on B27 neurons awaits the results of experiments with isolated B27 neurons, currently in progress.
Inhibitory glutamate receptors on B5, B19 and B27 neurons
Inhibitory effects of glutamate in invertebrates have been shown to be
mediated by both glutamate-gated chloride channels (GluCl–)
and mGluRs, sometimes in the same cells. GluCl– are found in
many invertebrate systems (Bolshakov et
al., 1991
; Cleland and
Selverston, 1995
; Cully et al.,
1994
; Katz and Levitan, 1983), and chloride has been implicated
along with potassium as the mediators of inhibitory currents in
Helisoma (Jones et al.,
1987
). Previous evidence from our laboratory indicates that the
chloride channel blocker niflumic acid is unable to prevent the
hyperpolarization and reduced AP frequency observed when glutamate is applied
to B5 and B19 neurons (Kleckner et al.,
2003
). In addition, Ca2+ and Ba2+ have been
shown to block glutamate-induced hyperpolarization of isolated B5 and B19
neurons (Rafferty and Kleckner,
2005
), suggesting the effect is mediated through K+
channels. Vertebrate inhibitory mGluRs, which include the group II and III
mGluR subtypes, are often coupled with G protein-coupled inwardly rectifying
K+ channels (GIRKs). Following the binding of glutamate to group II
or III mGluRs, a G protein belonging to the Gi/o class may activate
a GIRK, in addition to inhibition of adenylyl cyclase, resulting in the efflux
of K+ to produce hyperpolarization
(Knoflach and Kemp, 1998
).
Supporting the role of this pathway in glutamate-induced inhibition in
Helisoma, pertussis toxin was shown to block hyperpolarization of B5
and B19 neurons by glutamate (Rafferty and
Kleckner, 2005
). Similar receptors, responsive to quisqualate,
ACPD and L-AP4, have also been found in Drosophila nervous
system (Parmentier et al.,
1996
).
Evidence supporting the presence of mGluRs in Helisoma buccal
neurons includes the reduction of AP frequency by quisqualate, an agonist that
interacts with all three groups of mGluR, in all three neurons tested.
However, the mGluR agonist ACPD, also relatively non-selective, reduced AP
frequency only in B5 neurons, indicating that at least two types of mGluR
exist on buccal neurons. A lack of sensitivity of B19 and B27 neurons to ACPD
despite activation by quisqualate suggests that group III mGluRs might be
involved, since these receptors have a lower affinity for ACPD (>300
µmol l–1) than receptors in groups I or II
(Conn and Pin, 1997
). However,
neither B19 nor B27 neurons were inhibited by the selective group III agonist
L-AP4, suggesting that these receptors have a unique agonist
pharmacology. This pharmacology also distinguishes the receptors in B19 and
B27 from those cloned from Drosophila (DmGluRA)
(Parmentier et al., 1996
),
which did respond to L-AP4. Invertebrate glutamate receptors with
unique pharmacology compared with vertebrate receptors have been found in
networks of the Pacific spiny lobster (Panulirus interruptus)
stomatogastric ganglia, which are largely regulated by glutamate. These
neurons did not respond to quisqualate, KA, AMPA or NMDA
(Cleland and Selverston,
1995
).
Interestingly, a small but not significant trend toward excitation in
response to DHPG occurred in B27, suggesting the possible presence of
receptors resembling group I mGluRs on this neuron. In vertebrates, group I
mGluRs are excitatory, causing slow depolarization through the activation of
phospholipase C. Gq proteins activate phospholipase C, which then
activates diacylglycerol and inositol triphosphate as second messengers to
open ion channels. Gq proteins may also open ion channels directly
without acting through second messengers
(Meldrum, 2000
;
Sharon et al., 1997
;
Slattery et al., 2006
).
Perhaps robust excitation of B27 within the feeding CPG occurs as a result of
both excitatory iGluRs resembling KA receptors and excitatory mGluRs
resembling vertebrate group I mGluRs. However, the possible presence of group
I mGluR-like excitatory receptors does not account for the inhibitory effect
of quisqualate on B27, which suggests that a population of inhibitory mGluRs
with unique pharmacology is also present.
Thus, it is difficult to classify the inhibitory receptor populations in
these buccal neurons based on any known receptor pharmacology. Future
classification of receptors in buccal neurons should be done in isolated
neurons to prevent issues of synaptic and electrotonic coupling, and should
include the motor neurons B6, B7 and B8 since these neurons are driven more
directly by S1 interneurons (Quinlan and
Murphy, 1991
; Quinlan and
Murphy, 1996
) and are therefore more likely to fire
consistently.
Excitatory glutamate receptors on B5, B19 and B27 neurons
Activation of vertebrate KA receptors, most often of the GluR5 or GluR6
type, has been shown to activate inhibitory metabotropic glutamate receptors
in a variety of vertebrate systems
(Grabauskas et al., 2007
;
Partovi and Frerking, 2006
;
Schmidt et al., 1999
), so,
given the inhibition of B5 neurons by 10 µmol l–1 KA in
this study, the possibility exists that Helisoma has similar KA
receptors and mGluRs to cause this effect. GluR5/6-containing KA receptors
have an affinity for KA in the nmol l–1 range
(Egeberg et al., 1991
),
consistent with activation by a relatively low concentration of KA. At higher
concentrations, KA acting at AMPA receptors, which have higher µmol
l–1 affinities (30–100 µmol l–1)
(Hollmann et al., 1989
), might
be responsible for depolarization and the increased frequency of firing.
Immunoreactivity to a vertebrate GluR5/6/7 antibody has been observed in both
Helisoma buccal ganglia (Marya et
al., 2007
) and leech CNS
(Thorogood et al., 1999
).
However, B5 was not among the neurons labeled in Helisoma. Similar to
the experiments with metabotropic agonists, B5 neurons had highly variable
firing rates, even under control conditions, so solid conclusions about the
nature of the receptors present in these neurons might need to await the
cloning, expression and localization of the receptors or characterization in
other neurons inhibited by glutamate (e.g. B6, 7, 8).
KA-mediated reduction in firing rate might also have been due to the actions of KA at KA/AMPA receptors located on other neurons, which make synapses onto B5 neurons to cause inhibition. This effect would most likely be due to the presence of GluR5 or 6 receptors with relatively high affinities. Higher concentrations of KA might then act directly on AMPA receptors on B5 neurons to depolarize them. Experiments with isolated neurons or with blockers of synaptic transmission are needed to determine the precise mechanism.
Unlike the results in B5 neurons, 30 µmol l–1 KA
consistently stimulated B19 and B27 neurons, suggesting the presence of
ionotropic receptors resembling vertebrate AMPA or KA receptors. Given that KA
was not able to depolarize isolated B19 neurons, it is likely that the effects
of KA on both neurons are mediated through receptors on B27 neurons. However,
the vertebrate AMPA/KA receptor antagonist CNQX partially blocked the
KA-induced increase in firing rate in B27 neurons, but not in B19 neurons.
Importantly, only a concentration of CNQX that is five to ten times the
effective concentration against most vertebrate AMPA/KA receptors
(Honore et al., 1989
) caused
inhibition of KA stimulation, and even then only at low KA concentrations. The
ability of 30 µmol l–1 KA to stimulate AP firing suggests
similarity to vertebrate AMPA receptors, which have EC50 values for
KA of 30 to 110 µmol l–1 for cloned receptors from rat;
these values contrast with those of vertebrate KA receptors, which have nmol
l–1 to low µmol l–1 affinities for KA
(reviewed in Hollmann and Heinemann,
1994
). Thus, it appears that glutamate and KA binding affinities
may have changed very little over evolutionary time, whereas antagonist
binding affinities have changed. Given the lack of selective pressure to
maintain the additional sites required for binding of a modern synthetic
antagonist like CNQX, this finding is not altogether surprising.
| CONCLUSION |
|---|
|
|
|---|
Inhibition by glutamate is most likely to occur through mGluRs whose signal
transduction pathways most closely resemble group II or III vertebrate
receptors. Multiple subtypes with differential sensitivity to ACPD are likely
to be present in different neurons, and the pharmacology of receptors in each
type of neuron does not match the known receptor pharmacology of vertebrate
receptors (Conn and Pin, 1997
)
or receptors from Drosophila nervous system
(Parmentier et al., 1996
).
Because of the lack of effective antagonists for each of these receptors, more
detailed pharmacological characterization may await cloning and expression of
receptors, and localization to buccal neurons through in situ
hybridization. Experiments are also underway in which glutamate receptor
agonists are applied to isolated identified buccal neurons.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Bolshakov, V. Y., Gapon, S. A. and Magazanic, L. G.
(1991). Different types of glutamate receptors in isolated and
identified neurones of the mollusc Planorbarius corneus. J.
Physiol. 439,15
-35.
Cleland, T. A. (1996). Inhibitory glutamate receptor channels. Mol. Neurobiol. 13, 97-136.[Medline]
Cleland, T. A. and Selverston, A. I. (1995).
Glutamate-gated inhibitory currents of central pattern generator neurons in
the lobster stomatogastric ganglion. J. Neurosci.
15,6631
-6639.
Conn, P. J. and Pin, J.-P. (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37,205 -237.[CrossRef][Medline]
Cully, D. F., Vassilatis, D. K., Liu, K. K., Paress, P. S., Van der Ploeg, L. H. T., Schaeffer, H. M. and Arena, H. P. (1994). Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371,707 -711.[CrossRef][Medline]
Egeberg, J., Bettler, B., Hermans-Borgmeyer, I. and Heinemann, S. (1991). Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature 351,745 -748.[CrossRef][Medline]
Grabauskas, G., Lancaster, B., O'Conner, V. and Wheal, H. V.
(2007). Protein kinase signaling requirements for metabotropic
action of kainate receptors in rat CA1 pyramidal neurons. J.
Physiol. 579,363
-373.
Hadley, R. D., Bodnar, D. A. and Kater, S. B. (1985). Formation of electrical synapses between isolated, cultured Helisoma neurons requires mutual neurite elongation. J. Neurosci. 5,3145 -3153.[Abstract]
Haydon, P. G. and Man-Son-Hing, H. (1988). Low- and high-voltage-activated calcium currents: their relationship to the site of neurotransmitter release in an identified neuron of Helisoma.Neuron 1,919 -927.[CrossRef][Medline]
Hollmann, M. and Heinemann, S. (1994). Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.[CrossRef][Medline]
Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W. and Heinemann, S. (1989). Cloning by functional expression of a member of the glutamate receptor family. Science 342,643 -648.
Honore, T., Drejer, J., Nielsen, E. O. and Nielsen, M. (1989). Non-NMDA glutamate receptor antagonist 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors. Biochem. Pharmacol. 38,3207 -3212.[CrossRef][Medline]
Jones, P. G., Rosser, S. J. and Bulloch, A. G. (1987). Glutamate suppression of feeding and the underlying output of effector neurons in Helisoma. Brain Res. 437, 56-68.[CrossRef][Medline]
Katz, P. S. and Levitan, I. B. (1993).
Quisqualate and ACPD are agonists for a glutamate-activated current in
identified Aplysia neurons. J. Neurophysiol.
69,143
-150.
Kleckner, N. W., Percarpio, K. and Fink, K. (2003). Intracellular signaling pathways linked to glutamate inhibition of neurons involved in feeding behavior in the pond snail, Helisoma. Soc. Neurosci. Abstr. 2003, 44.9.
Knoflach, F. and Kemp, J. A. (1998).
Metabotropic glutamate group II receptors activate a G protein-coupled
inwardly rectifying K+ current in eurons of the rat cerebellum. J.
Physiol. Lond. 509,347
-354.
Marya, N., Sousa, G. L. and Kleckner, N. W. (2007). Characterization and mapping of glutamate receptor-containing neurons in Helisoma trivolvis. Soc. Neurosci. Abstr. 2007,140.3 .
Meldrum, B. S. (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 130,1007S -1015S.[Medline]
Murphy, A. D. (2001). The neuronal basis of feeding in the snail, Helisoma, with comparisons to selected gastropods. Prog. Neurobiol. 63,383 -408.[CrossRef][Medline]
Parmentier, M., Pin, J.-P., Bockaert, J. and Grau, Y.
(1996). Cloning and functional expression of Drosophila
metabotropic glutamate receptor expressed in the embryonic CNS. J.
Neurosci. 16,6687
-6694.
Partovi, D. and Frerking, M. (2006). Presynaptic inhibition by kainate receptors converges mechanistically with presynaptic inhibition by adenosine and GABAB receptors. Neuropharmacology 51,1030 -1037.[CrossRef][Medline]
Quinlan, E. M. and Murphy, A. D. (1991).
Glutamate as a putative neurotransmitter in the buccal central pattern
generator of Helisoma. J. Neurophysiol.
66,1264
-1271.
Quinlan, E. M. and Murphy, A. D. (1996).
Plasticity in the multifunctional buccal central pattern generator of
Helisoma illuminated by the identification of phase 3 interneurons.
J. Neurophysiol. 75,561
-574.
Quinlan, E. M., Gregory, K. and Murphy, A. D.
(1995). An identified glutamatergic interneuron patterns feeding
motor activity via both excitation and inhibition. J.
Neurophysiol. 73,945
-956.
Rafferty, J. R. and Kleckner, N. W. (2005). Glutamate signal transduction pathways causing inhibition in buccal neurons of Helisoma trivolvis. Soc. Neurosci. Abstr. 2005,263.9 .
Schmidt, J., Prinz, P. and Deitmer, J. W. (1999). Glial hyperpolarization upon nerve root stimulation in the leech Hirudo medicinalis. Glia 27, 32-38.[CrossRef][Medline]
Sharon, D., Vorobiov, D. and Dascal, N. (1997).
Positive and negative coupling of the metabotropic glutamate receptors to a G
protein-activated K+ channel, GIRK, in Xenopus oocytes. J.
Gen. Physiol. 109,477
-490.
Slattery, J. A., Page, A. J., Dorian, C., Brierley, S. and
Blackshaw, L. A. (2006). Potentiation of mouse vagal afferent
mechanosensitivity by ionotropic and metabotropic glutamate receptors.
J. Physiol. 577,295
-306.
Stuhmer, T., Amar, N., Harvey, R. J., Bermudez, I., van Minnen,
J. and Darlison, M. G. (1996). Structure and pharmacological
properties of a molluscan glutamate-gated cation channel and its likely role
in feeding behavior. J. Neurosci.
16,2869
-2880.
Syed, N. I., Roger, I., Ridgway, R. L., Bauce, L. G., Lukowiak, K. and Bulloch, A. G. (1993). Identification, characterisation and in vitro reconstruction of an interneuronal network of the snail Helisoma trivolvis. J. Exp. Biol. 174, 19-44.[Abstract]
Thorogood, M. S. E., Almeida, V. W. and Brodfuehrer, P. D. (1999). Glutamate receptor 5/6/7-like and glutamate transporter-1-like immunoreactivity in the leech central nervous system. J. Comp. Neurol. 405,334 -344.[CrossRef][Medline]
Walker, R. J. (1976). The action of kainic acid and quisqualic acid on the glutamate receptors of three identifiable neurones from the brain of the snail, Helix aspersa. Comp. Biochem. Physiol. 55C,61 -67.[CrossRef][Medline]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||